1. Home
  2. FHTX vs AFRI Comparison

FHTX vs AFRI Comparison

Compare FHTX & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • AFRI
  • Stock Information
  • Founded
  • FHTX 2015
  • AFRI 1943
  • Country
  • FHTX United States
  • AFRI Gibraltar
  • Employees
  • FHTX N/A
  • AFRI N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • AFRI Packaged Foods
  • Sector
  • FHTX Health Care
  • AFRI Consumer Staples
  • Exchange
  • FHTX Nasdaq
  • AFRI Nasdaq
  • Market Cap
  • FHTX 237.4M
  • AFRI 275.5M
  • IPO Year
  • FHTX 2020
  • AFRI N/A
  • Fundamental
  • Price
  • FHTX $4.10
  • AFRI $9.60
  • Analyst Decision
  • FHTX Strong Buy
  • AFRI
  • Analyst Count
  • FHTX 6
  • AFRI 0
  • Target Price
  • FHTX $13.17
  • AFRI N/A
  • AVG Volume (30 Days)
  • FHTX 110.9K
  • AFRI 9.5K
  • Earning Date
  • FHTX 03-06-2025
  • AFRI 02-11-2025
  • Dividend Yield
  • FHTX N/A
  • AFRI N/A
  • EPS Growth
  • FHTX N/A
  • AFRI N/A
  • EPS
  • FHTX N/A
  • AFRI N/A
  • Revenue
  • FHTX $25,515,000.00
  • AFRI $325,098,000.00
  • Revenue This Year
  • FHTX N/A
  • AFRI N/A
  • Revenue Next Year
  • FHTX $7.37
  • AFRI N/A
  • P/E Ratio
  • FHTX N/A
  • AFRI N/A
  • Revenue Growth
  • FHTX N/A
  • AFRI 15.94
  • 52 Week Low
  • FHTX $2.81
  • AFRI $9.55
  • 52 Week High
  • FHTX $10.25
  • AFRI $12.00
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 38.20
  • AFRI 37.14
  • Support Level
  • FHTX $3.89
  • AFRI $9.56
  • Resistance Level
  • FHTX $4.64
  • AFRI $9.90
  • Average True Range (ATR)
  • FHTX 0.34
  • AFRI 0.19
  • MACD
  • FHTX 0.07
  • AFRI -0.01
  • Stochastic Oscillator
  • FHTX 30.77
  • AFRI 11.36

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About AFRI Forafric Global PLC

Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.

Share on Social Networks: